Research group leader
Prof. Dr. Kirsten R. Müller-Vahl
Excellence at a glance:
- Since 2020: President of the "European Society for the Study of Tourette syndrome" (ESSTS)
- Since 2019: 1st chairperson of the "International Association for Cannabinoids as Medicine" (IACM)
- Since 2019: 1st chairwoman of the Arbeitsgemeinschaft Cannabis als Medizin (ACM)
- 2019: Co-editor of the standard book on "Cannabis as medicine": Müller-Vahl KR, Grotenhermen F (Hrg). Cannabis as Medicine, Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft; 2020. ISBN: 978-3-95466-509-9
- From 2017-2019 several times active as individual expert in hearings in the German Bundestag on the "Cannabis Law”
- Since 2018: Editorial board member for "Medical Cannabis and Cannabinoids".
- 2017: IACM Award: "IACM Award for Clinical Research for her special achievements regarding the re-introduction of cannabis and cannabinoids as medicine
- Since 2017: Associate editor for "Cannabis and Cannabinoid Research"
- Since 2016: Member of the Expert Committee for Narcotics in the Federal Opium Agency of the Federal Institute for Drugs and Medical Devices (BfArM)
- 2014: Editor of the standard book on Tourette syndrome: Müller-Vahl K. Tourette syndrome and other tic disorders. 2nd, updated and extended edition, Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft; 2014. ISBN: 978-3-95466-099-5
- 2012: Science Prize of the Tourette Society Germany (TGD e.V.)
- Expert at the Federal Highway Research Institute (BAST)
- Study leader in numerous studies funded by DFG, BMBF, EU, NIMH and industry
- Specialist in psychiatry and specialist in neurology